ImmunoCAP

back to Abstracts

 

Mediators in allergy diagnosis

Staffan Ahlstedt

Allergy and Clinical Immunology International, Vol. 10, No. 2, 1998

Development of Allergic Disease—"Allergy March"

  • The development of allergic disease and allergic symptoms is a genetically determined, dynamic process involving IgE antibody formation, inflammatory reactions, and hyperresponsiveness to different stimuli. These pathologies must be taken into consideration for a correct diagnosis.

  • Allergic disease and prevalence of allergic symptoms are evolutionary, beginning in infancy and showing changing patterns in relation to age - referred to as the "allergy march."

  • Presence of allergic disease may precede symptoms; therefore, identifying the "allergy march" may be useful in predicting or perhaps even reversing allergy or allergy-related or allergy-complicated diseases.

  • There may be clinical usefulness of diagnostic tests in daily work for identifying the onset of allergic disease in different age groups.

Determining Presence of Mediators in Allergy
Though there are a number of mediators in allergy, determination of specific IgE antibodies is the most widely used diagnostic clinical routine.

In Vitro vs. In Vivo for Measuring IgE Antibodies

  • Presence of IgE antibodies can be demonstrated with in vitro and
    in vivo tests; however, to achieve accurate measurements, all components in a test system have to be standardized separately, as well as in combination, and be reproducible over time.

  • Variation of allergen concentrations in skin test solutions, as well as other factors, can shift results from more specific and less sensitive to more sensitive and less specific.

  • For practical, routine work, current in vitro immunoassay systems may be the most convenient tools for determining IgE antibodies because they are better standardized and may be more useful for examining the "allergy march."

  • Accurate and reproducible detection of specific IgE antibodies by
    in vitro testing with ImmunoCAP technology is demonstrated to correspond better to clinical diagnosis by allergy specialists than by
    in vivo skin prick testing.

Request full article